MiRXES eyes fuss-free early cancer tests; road ahead not easy
Local startup, which is heading towards a public listing, is doubling down on its acquisition strategy after a US$77m funding round
Singapore
IMAGINE if early-stage cancer testing was as fuss-free as taking a Covid PCR test or a blood test.
Homegrown startup MiRXES is hoping to bring such "liquid" cancer tests into our homes in about 5 to 10 years' time. If this dream pans out, a simple blood test could be able to detect all types of cancers at an early stage - when it is easier to treat and possibly cure.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Is it time to scrap COE categories for cars?
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
As more Asean states turn to Russia for fuel, will Moscow boost its influence in the region?